| Year |
Citation |
Score |
| 2023 |
Kübler D, Kobylecki C, McDonald KR, Anton-Rodriguez JM, Herholz K, Carter SF, Hinz R, Thompson JC, Al-Fatly B, Gerhard A. Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease. Parkinsonism & Related Disorders. 107: 105277. PMID 36621156 DOI: 10.1016/j.parkreldis.2022.105277 |
0.603 |
|
| 2022 |
Tomassen J, den Braber A, van der Lee SJ, Reus LM, Konijnenberg E, Carter SF, Yaqub M, van Berckel BNM, Collij LE, Boomsma DI, de Geus EJC, Scheltens P, Herholz K, Tijms BM, Visser PJ. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score. Bmc Neurology. 22: 484. PMID 36522743 DOI: 10.1186/s12883-022-02925-6 |
0.615 |
|
| 2022 |
Michalowska MM, Herholz K, Hinz R, Amadi C, McInnes L, Anton-Rodriguez JM, Karikari TK, Blennow K, Zetterberg H, Ashton NJ, Pendleton N, Carter SF. Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78-94. Molecular Psychiatry. PMID 35858992 DOI: 10.1038/s41380-022-01685-6 |
0.639 |
|
| 2022 |
Herholz K. Imaging Clinical Subtypes and Associated Brain Networks in Alzheimer's Disease. Brain Sciences. 12. PMID 35203910 DOI: 10.3390/brainsci12020146 |
0.385 |
|
| 2020 |
Chételat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, van de Giessen E, Agosta F, Barkhof F, Brooks DJ, Carrillo MC, Dubois B, Fjell AM, Frisoni GB, Hansson O, ... Herholz K, et al. Amyloid-PET and F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. The Lancet. Neurology. 19: 951-962. PMID 33098804 DOI: 10.1016/S1474-4422(20)30314-8 |
0.353 |
|
| 2020 |
Mada MO, Hindmarch P, Stirling J, Davies J, Brian D, Barnes A, Hammers A, Gulliver N, Herholz K, O'Brien J, Taylor JP. Competencies and training of radiographers and technologists for PET/MR imaging - a study from the UK MR-PET network. European Journal of Hybrid Imaging. 4: 1. PMID 32025619 DOI: 10.1186/S41824-019-0070-6 |
0.371 |
|
| 2020 |
Herholz K. Hide-and-seek for radiotracers and neurodegenerative pathology. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31897583 DOI: 10.1007/S00259-019-04661-5 |
0.354 |
|
| 2019 |
Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER. Astrocyte Biomarkers in Alzheimer's Disease. Trends in Molecular Medicine. PMID 30611668 DOI: 10.1016/J.Molmed.2018.11.006 |
0.617 |
|
| 2019 |
Asghar M, Hinz R, Herholz K, Carter SF. Dual-phase [18F]florbetapir in frontotemporal dementia. European Journal of Nuclear Medicine and Molecular Imaging. 46: 304-311. PMID 30569187 DOI: 10.1007/S00259-018-4238-2 |
0.657 |
|
| 2018 |
Legdeur N, Badissi M, Carter SF, de Crom S, van de Kreeke A, Vreeswijk R, Trappenburg MC, Oudega ML, Koek HL, van Campen JP, Keijsers CJPW, Amadi C, Hinz R, Gordon MF, Novak G, ... ... Herholz K, et al. Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study. Bmc Geriatrics. 18: 289. PMID 30477432 DOI: 10.1186/S12877-018-0984-Z |
0.607 |
|
| 2018 |
Konijnenberg E, Carter SF, Ten Kate M, den Braber A, Tomassen J, Amadi C, Wesselman L, Nguyen HT, van de Kreeke JA, Yaqub M, Demuru M, Mulder SD, Hillebrand A, Bouwman FH, Teunissen CE, ... ... Herholz K, et al. The EMIF-AD PreclinAD study: study design and baseline cohort overview. Alzheimer's Research & Therapy. 10: 75. PMID 30075734 DOI: 10.1186/S13195-018-0406-7 |
0.667 |
|
| 2018 |
Drzezga A, Altomare D, Festari C, Arbizu J, Orini S, Herholz K, Nestor P, Agosta F, Bouwman F, Nobili F, Walker Z, Frisoni GB, Boccardi M. Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 29756163 DOI: 10.1007/s00259-018-4032-1 |
0.399 |
|
| 2018 |
Hampel H, Toschi N, Babiloni C, Baldacci F, Black KL, Bokde ALW, Bun RS, Cacciola F, Cavedo E, Chiesa PA, Colliot O, Coman CM, Dubois B, Duggento A, Durrleman S, ... ... Herholz K, et al. Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology. Journal of Alzheimer's Disease : Jad. PMID 29562524 DOI: 10.3233/Jad-179932 |
0.304 |
|
| 2018 |
Holmes C, Sussams R, Gerhard A, Herholz K, Jacobs AH. F4-06-02: Insights From Clinical Research On The Timing And Trajectory Of Immune Activation In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2885 |
0.336 |
|
| 2018 |
Herholz K. PET and MRI in gliomas: progress and perspectives Clinical and Translational Imaging. 6: 73-75. DOI: 10.1007/S40336-017-0258-3 |
0.403 |
|
| 2017 |
Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hansson O, Herholz K, Jack CR, Nobili F, Nordberg A, et al. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. The Lancet. Neurology. 16: 661-676. PMID 28721928 DOI: 10.1016/S1474-4422(17)30159-X |
0.679 |
|
| 2017 |
Herholz K, Haense C, Gerhard A, Jones M, Anton-Rodriguez J, Segobin S, Snowden JS, Thompson JC, Kobylecki C. Metabolic regional and network changes in Alzheimer's disease subtypes. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17718436. PMID 28675110 DOI: 10.1177/0271678X17718436 |
0.454 |
|
| 2017 |
Sonni I, Ratib O, Boccardi M, Picco A, Herholz K, Nobili F, Varrone A. Clinical validity of presynaptic dopaminergic imaging with (123)I-ioflupane and noradrenergic imaging with (123)I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 228-242. PMID 28317651 DOI: 10.1016/J.Neurobiolaging.2016.04.026 |
0.381 |
|
| 2017 |
Chiotis K, Saint-Aubert L, Boccardi M, Gietl A, Picco A, Varrone A, Garibotto V, Herholz K, Nobili F, Nordberg A. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 214-227. PMID 28317650 DOI: 10.1016/J.Neurobiolaging.2016.07.012 |
0.722 |
|
| 2017 |
Garibotto V, Herholz K, Boccardi M, Picco A, Varrone A, Nordberg A, Nobili F, Ratib O. Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 183-195. PMID 28317648 DOI: 10.1016/J.Neurobiolaging.2016.03.033 |
0.458 |
|
| 2017 |
Kobylecki C, Haense C, Harris JM, Stopford CL, Segobin SH, Jones M, Richardson AM, Gerhard A, Anton-Rodriguez J, Thompson JC, Herholz K, Snowden JS. Functional neuroanatomical associations of working memory in early-onset Alzheimer's disease. International Journal of Geriatric Psychiatry. PMID 28299814 DOI: 10.1002/Gps.4703 |
0.352 |
|
| 2017 |
Herholz K. Brain Tumors: An Update on Clinical PET Research in Gliomas. Seminars in Nuclear Medicine. 47: 5-17. PMID 27987557 DOI: 10.1053/J.Semnuclmed.2016.09.004 |
0.381 |
|
| 2017 |
Su Z, Roncaroli F, Hinz R, Karabatsou K, Coope D, Turkheimer F, Jenkinson M, Jackson A, Herholz K, Gerhard A. Microglial activation in normal-appearing brain regions of patients with cerebral glioma: a cross-sectional study The Lancet. 389. DOI: 10.1016/S0140-6736(17)30488-9 |
0.362 |
|
| 2017 |
Michou E, Trender-Gerhard I, Gerhard A, Craufurd D, Herholz K, Hamdy S. Pilot Observations from a Multimodal Imaging Study of Dysphagic Patients in Early Stage Huntington'S Disease Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)33166-9 |
0.314 |
|
| 2016 |
Herholz K. Tau PET and tauopathies. European Journal of Nuclear Medicine and Molecular Imaging. 43: 1684-5. PMID 27160223 DOI: 10.1007/S00259-016-3406-5 |
0.41 |
|
| 2016 |
Roncaroli F, Su Z, Herholz K, Gerhard A, Turkheimer FE. TSPO expression in brain tumours: is TSPO a target for brain tumour imaging? Clinical and Translational Imaging. 4: 145-156. PMID 27077069 DOI: 10.1007/S40336-016-0168-9 |
0.368 |
|
| 2016 |
Carter SF, Parkes L, Hinz R, Herholz K. P4-343: Cerebral Brain Perfusion in Cognitively Normal Advanced Elderly (79-93 Years) Measured with Arterial Spin Labelling and [18F]Flutemetamol PET: A Cross Modality Comparison Alzheimer's & Dementia. 12: P1166-P1166. DOI: 10.1016/J.Jalz.2016.07.087 |
0.648 |
|
| 2016 |
Legdeur N, Herholz K, Carter SF, Gordon MF, Novak GP, Li DJ, Scheltens P, Maier AB, Visser PJ. P2-165: Resilience to Clinical Dementia at Old Age: The European Medical Information Framework (EMIF) 90+ Study Alzheimer's & Dementia. 12: P678-P678. DOI: 10.1016/J.Jalz.2016.06.1332 |
0.591 |
|
| 2015 |
Lista S, Molinuevo JL, Cavedo E, Rami L, Amouyel P, Teipel SJ, Garaci F, Toschi N, Habert MO, Blennow K, Zetterberg H, O'Bryant SE, Johnson L, Galluzzi S, Bokde AL, ... Herholz K, et al. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline. Journal of Alzheimer's Disease : Jad. PMID 26402088 DOI: 10.3233/Jad-150202 |
0.426 |
|
| 2015 |
O'Brien JT, Herholz K. Amyloid imaging for dementia in clinical practice. Bmc Medicine. 13: 163. PMID 26170121 DOI: 10.1186/S12916-015-0404-6 |
0.442 |
|
| 2015 |
Firbank MJ, Lloyd J, Williams D, Barber R, Colloby SJ, Barnett N, Olsen K, Davison C, Donaldson C, Herholz K, O'Brien JT. An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer's disease according to presence of medial temporal lobe atrophy. The British Journal of Psychiatry : the Journal of Mental Science. PMID 26045347 DOI: 10.1192/Bjp.Bp.114.160804 |
0.374 |
|
| 2015 |
Su Z, Roncaroli F, Durrenberger PF, Coope DJ, Karabatsou K, Hinz R, Thompson G, Turkheimer FE, Janczar K, Du Plessis D, Brodbelt A, Jackson A, Gerhard A, Herholz K. The 18-kDa mitochondrial translocator protein in human gliomas: an 11C-(R)PK11195 PET imaging and neuropathology study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 512-7. PMID 25722450 DOI: 10.2967/Jnumed.114.151621 |
0.32 |
|
| 2015 |
Kobylecki C, Langheinrich T, Hinz R, Vardy ER, Brown G, Martino ME, Haense C, Richardson AM, Gerhard A, Anton-Rodriguez JM, Snowden JS, Neary D, Pontecorvo MJ, Herholz K. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 386-91. PMID 25655625 DOI: 10.2967/Jnumed.114.147454 |
0.472 |
|
| 2014 |
Cavedo E, Lista S, Khachaturian Z, Aisen P, Amouyel P, Herholz K, Jack CR, Sperling R, Cummings J, Blennow K, O'Bryant S, Frisoni GB, Khachaturian A, Kivipelto M, Klunk W, et al. The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. The Journal of Prevention of Alzheimer's Disease. 1: 181-202. PMID 26478889 DOI: 10.14283/jpad.2014.32 |
0.321 |
|
| 2014 |
O'Brien JT, Firbank MJ, Davison C, Barnett N, Bamford C, Donaldson C, Olsen K, Herholz K, Williams D, Lloyd J. 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1959-65. PMID 25453043 DOI: 10.2967/Jnumed.114.143347 |
0.468 |
|
| 2014 |
Herholz K, Evans R, Anton-Rodriguez J, Hinz R, Matthews JC. The effect of 18F-florbetapir dose reduction on region-based classification of cortical amyloid deposition. European Journal of Nuclear Medicine and Molecular Imaging. 41: 2144-9. PMID 25002030 DOI: 10.1007/S00259-014-2842-3 |
0.346 |
|
| 2014 |
Carter SF, Embleton KV, Anton-Rodriguez JM, Burns A, Ralph MA, Herholz K. Regional neuronal network failure and cognition in late-onset sporadic Alzheimer disease. Ajnr. American Journal of Neuroradiology. 35: S18-30. PMID 24578281 DOI: 10.3174/Ajnr.A3895 |
0.64 |
|
| 2014 |
Kerklaan BJ, van Berckel BN, Herholz K, Dols A, van der Flier WM, Scheltens P, Pijnenburg YA. The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia. American Journal of Alzheimer's Disease and Other Dementias. 29: 607-13. PMID 24576796 DOI: 10.1177/1533317514524811 |
0.455 |
|
| 2014 |
Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. P3-215: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P709-P710. DOI: 10.1016/j.jalz.2014.05.1306 |
0.586 |
|
| 2014 |
Farid K, Almkvist O, Brueggen K, Carter SF, Wall A, Herholz K, Nordberg A. IC-P-019: HIGH PUTAMEN 11C-PIB RETENTION IN MCI IS ASSOCIATED WITH AN INCREASED RISK OF CONVERSION TO AD Alzheimer's & Dementia. 10: P16-P16. DOI: 10.1016/J.Jalz.2014.05.023 |
0.608 |
|
| 2014 |
Herholz K. The role of PET quantification in neurological imaging: FDG and amyloid imaging in dementia Clinical and Translational Imaging. 2: 321-330. DOI: 10.1007/S40336-014-0073-Z |
0.466 |
|
| 2013 |
Herholz SC, Herholz RS, Herholz K. Non-pharmacological interventions and neuroplasticity in early stage Alzheimer's disease. Expert Review of Neurotherapeutics. 13: 1235-45. PMID 24134650 DOI: 10.1586/14737175.2013.845086 |
0.353 |
|
| 2013 |
Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, et al. Imaging markers for Alzheimer disease: which vs how. Neurology. 81: 487-500. PMID 23897875 DOI: 10.1212/Wnl.0B013E31829D86E8 |
0.419 |
|
| 2013 |
Boutin H, Prenant C, Maroy R, Galea J, Greenhalgh AD, Smigova A, Cawthorne C, Julyan P, Wilkinson SM, Banister SD, Brown G, Herholz K, Kassiou M, Rothwell NJ. [18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats. Plos One. 8: e56441. PMID 23418569 DOI: 10.1371/Journal.Pone.0056441 |
0.343 |
|
| 2013 |
Prestia A, Caroli A, Herholz K, Reiman E, Chen K, Jagust WJ, Frisoni GB. Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 677-86. PMID 23375562 DOI: 10.1016/J.Jalz.2012.09.016 |
0.433 |
|
| 2013 |
Edison P, Carter SF, Rinne JO, Gelosa G, Herholz K, Nordberg A, Brooks DJ, Hinz R. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. Neuroimage. 70: 423-33. PMID 23261639 DOI: 10.1016/J.Neuroimage.2012.12.014 |
0.702 |
|
| 2013 |
Yeh HH, Tian M, Hinz R, Young D, Shavrin A, Mukhapadhyay U, Flores LG, Balatoni J, Soghomonyan S, Jeong HJ, Pal A, Uthamanthil R, Jackson JN, Nishii R, Mizuma H, ... ... Herholz K, et al. Imaging epigenetic regulation by histone deacetylases in the brain using PET/MRI with ¹â¸F-FAHA. Neuroimage. 64: 630-9. PMID 22995777 DOI: 10.1016/J.Neuroimage.2012.09.019 |
0.38 |
|
| 2013 |
Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Forsberg A, Långström B, Scheinin N, Karrasch M, Någren K, Grimmer T, Miederer I, Edison P, ... ... Herholz K, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 40: 104-14. PMID 22961445 DOI: 10.1007/S00259-012-2237-2 |
0.696 |
|
| 2013 |
Kobylecki C, Langheinrich T, Hinz R, Vardy ER, Martino M, Richardson AM, Snowden JS, Anton-Rodriguez J, Neary D, Mann DM, Gerhard A, Herholz K. A positron emission tomography study of [18f]-florbetapir in Alzheimer's disease and frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry. 84. DOI: 10.1136/Jnnp-2013-306573.84 |
0.471 |
|
| 2013 |
Caroli A, Prestia A, Wade S, Chen K, Ayutyanont N, Landau S, Madison C, Haense C, Herholz K, Reiman E, Jagust W, Frisoni G. Alzheimer's disease biomarkers as outcome measures for clinical trials Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.1455 |
0.317 |
|
| 2013 |
Herholz K, Boecker H, Nemeth I, Dunn G. FDG PET in dementia multicenter studies and clinical trials Clinical and Translational Imaging. 1: 261-270. DOI: 10.1007/S40336-013-0018-Y |
0.466 |
|
| 2012 |
Herholz K. Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer's disease. Biomarkers in Medicine. 6: 431-9. PMID 22917145 DOI: 10.2217/Bmm.12.51 |
0.473 |
|
| 2012 |
Herholz K. Imaging cerebral amyloid plaques: clinical perspective. The Lancet. Neurology. 11: 652-3. PMID 22749064 DOI: 10.1016/S1474-4422(12)70158-8 |
0.34 |
|
| 2012 |
Marcone A, Garibotto V, Moresco RM, Florea I, Panzacchi A, Carpinelli A, Virta JR, Tettamanti M, Borroni B, Padovani A, Bertoldo A, Herholz K, Rinne JO, Cappa SF, Perani D. [11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis. Journal of Alzheimer's Disease : Jad. 31: 387-99. PMID 22596267 DOI: 10.3233/Jad-2012-111748 |
0.499 |
|
| 2012 |
Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust WJ, Frisoni GB. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 592-600. PMID 22343502 DOI: 10.2967/Jnumed.111.094946 |
0.488 |
|
| 2012 |
Bohnen NI, Djang DS, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 59-71. PMID 22173840 DOI: 10.2967/Jnumed.111.096578 |
0.471 |
|
| 2012 |
Carter SF, Caine D, Burns A, Herholz K, Lambon Ralph MA. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease. International Journal of Geriatric Psychiatry. 27: 423-32. PMID 21618285 DOI: 10.1002/Gps.2738 |
0.624 |
|
| 2012 |
Haense C, Kalbe E, Herholz K, Hohmann C, Neumaier B, Krais R, Heiss WD. Cholinergic system function and cognition in mild cognitive impairment. Neurobiology of Aging. 33: 867-77. PMID 20961662 DOI: 10.1016/J.Neurobiolaging.2010.08.015 |
0.433 |
|
| 2012 |
Teipel S, Sperling RA, Skudlarski P, Jack C, Hampel H, Fellgiebel A, Herholz K. MRI- and PET-based imaging markers for the diagnosis of Alzheimer's disease Advances in Biological Psychiatry. 28: 80-114. DOI: 10.1159/000335393 |
0.328 |
|
| 2012 |
Lewis J, Anton-Rodriguez J, Carter SF, Herholz K, Asselin MC, Hinz R. Optimization of high resolution PET iterative reconstruction with resolution modeling for image derived input function Ieee Nuclear Science Symposium Conference Record. 3999-4004. DOI: 10.1109/NSSMIC.2012.6551916 |
0.599 |
|
| 2012 |
Prestia A, Caroli A, Herholz K, Reiman E, Jagust W, Chen K, Frisoni G. Accuracy of different biomarkers to predict progression from mild cognitive impairment to probable Alzheimer's dementia in two independent clinical series Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.426 |
0.381 |
|
| 2011 |
Herholz K, Westwood S, Haense C, Dunn G. Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1218-26. PMID 21764801 DOI: 10.2967/Jnumed.111.090902 |
0.486 |
|
| 2011 |
Herholz K. Perfusion SPECT and FDG-PET. International Psychogeriatrics. 23: S25-31. PMID 21729421 DOI: 10.1017/S1041610211000937 |
0.509 |
|
| 2011 |
Herholz K, Ebmeier K. Clinical amyloid imaging in Alzheimer's disease. The Lancet. Neurology. 10: 667-70. PMID 21683932 DOI: 10.1016/S1474-4422(11)70123-5 |
0.41 |
|
| 2011 |
Markiewicz PJ, Matthews JC, Declerck J, Herholz K. Verification of predicted robustness and accuracy of multivariate analysis. Neuroimage. 56: 1382-1385. PMID 21338696 DOI: 10.1016/J.Neuroimage.2011.02.036 |
0.427 |
|
| 2011 |
Cawthorne C, Prenant C, Smigova A, Julyan PJ, Maroy R, Herholz K, Rothwell N, Boutin H. Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [18F]-IL1RA and PET imaging in rats British Journal of Pharmacology. 162: 659-672. PMID 20942812 DOI: 10.1111/J.1476-5381.2010.01068.X |
0.323 |
|
| 2011 |
Kalbe E, Onur OA, Minnerop M, Reimann J, Althaus A, Ahmadzadehfar H, Dodel R, Strach K, Clemen CS, Herholz K, Haense C, Fink GR, Schröder R. Early signs of VCP-related frontotemporal dementia: a neuropsychological, FDG-PET and fMRI study. Journal of Neurology. 258: 515-8. PMID 20938780 DOI: 10.1007/S00415-010-5774-2 |
0.387 |
|
| 2011 |
Merhof D, Markiewicz PJ, Platsch G, Declerck J, Weih M, Kornhuber J, Kuwert T, Matthews JC, Herholz K. Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 371-83. PMID 20628401 DOI: 10.1038/Jcbfm.2010.112 |
0.363 |
|
| 2011 |
Haense C, Segobin SH, Pridham J, Anton-Rodriguez JM, Stopford CL, Snowden JS, Herholz K. Patterns of 18F-FDG PET in different subtypes of Alzheimer’s disease F1000research. 2. DOI: 10.7490/F1000Research.1872.1 |
0.394 |
|
| 2011 |
Herholz K. Amyloid PET: Its diagnostic potential compared to FDG MéDecine NucléAire. 35: 322-326. DOI: 10.1016/J.MEDNUC.2011.02.007 |
0.321 |
|
| 2011 |
Herholz K. Fluorinated Amyloid Ligands for PET Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2426 |
0.381 |
|
| 2011 |
Haense C, Segobin S, Pridham J, Anton-Rodriguez J, Stopford C, Snowden J, Herholz K. Patterns of 18F-FDG PET in different subtypes of Alzheimer' disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2117 |
0.427 |
|
| 2010 |
Herholz K. Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease. Expert Review of Neurotherapeutics. 10: 1667-73. PMID 20977325 DOI: 10.1586/Ern.10.136 |
0.49 |
|
| 2010 |
Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nature Reviews. Drug Discovery. 9: 560-74. PMID 20592748 DOI: 10.1038/Nrd3115 |
0.353 |
|
| 2010 |
Tolboom N, van der Flier WM, Boverhoff J, Yaqub M, Wattjes MP, Raijmakers PG, Barkhof F, Scheltens P, Herholz K, Lammertsma AA, van Berckel BN. Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 882-4. PMID 20543188 DOI: 10.1136/Jnnp.2009.194779 |
0.431 |
|
| 2010 |
Herholz K. Amino acid PET and clinical management of glioma patients. European Journal of Nuclear Medicine and Molecular Imaging. 37: 683-4. PMID 20107786 DOI: 10.1007/S00259-009-1366-8 |
0.321 |
|
| 2010 |
Galldiks N, Kracht LW, Berthold F, Miletic H, Klein JC, Herholz K, Jacobs AH, Heiss WD. [11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors. Journal of Neuro-Oncology. 96: 231-9. PMID 19575148 DOI: 10.1007/S11060-009-9953-X |
0.35 |
|
| 2010 |
Terrière E, Dempsey MF, Herrmann LL, Tierney KM, Lonie JA, O'Carroll RE, Pimlott S, Wyper DJ, Herholz K, Ebmeier KP. 5-(123)I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment. Neurobiology of Aging. 31: 1885-93. PMID 19036475 DOI: 10.1016/J.Neurobiolaging.2008.10.008 |
0.365 |
|
| 2010 |
Vardy ERLC, Langheinrich T, Hinz R, Snowden JS, Gerhard A, Richardson AMT, Neary D, Anton J, Brown GD, Herholz K. POD14 Amyloid PET using 18F-AV-45 in Alzheimer's disease and frontotemporal dementia: first UK results Journal of Neurology, Neurosurgery, and Psychiatry. 81. DOI: 10.1136/Jnnp.2010.226340.114 |
0.467 |
|
| 2010 |
Coope D, Su Z, Gerhard A, Hinz R, Thompson G, Karabatsou K, Janczar K, Du PD, Roncaroli F, Turkheimer F, Jackson A, Herholz K, Miller P. In Vivo Imaging of Translocator Protein Expression in Low-Grade Gliomas by Positron Emission Tomography. In: Abstracts from the BNOS meeting, 23-25 June 2010, Glasgow. Neuro-Oncology. DOI: 10.1093/Neuonc/Noq041 |
0.327 |
|
| 2010 |
Carter SF, Burns A, Lambon Ralph MA, Herholz K. Longitudinal confirmation of a dissociation between tissue loss and functional impairment in MCI and late-onset Alzheimer's Alzheimer's & Dementia. 6: S300. DOI: 10.1016/J.Jalz.2010.05.981 |
0.634 |
|
| 2010 |
Herholz K. Molecular imaging in Alzheimer's Disease Alzheimers & Dementia. 6: 16-20. DOI: 10.1016/J.Jalz.2010.05.515 |
0.478 |
|
| 2010 |
Vardy ERLC, Hinz R, Langheinrich T, Snowden J, Gerhard A, Richardson AMT, Anton J, Brown GD, Neary D, Herholz K. Amyloid PET using 18F-AV45 in Frontotemporal Dementia Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.099 |
0.423 |
|
| 2010 |
Haense C, Kalbe E, Herholz K, Hohmann C, Neumaier B, Krais R, Heiss W. Cholinergic and Neuropsychological Function in Mild Cognitive Impairment Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.086 |
0.309 |
|
| 2009 |
Markiewicz P, Matthews J, Declerck J, Herholz K. Robustness of correlations between PCA of FDG-PET scans and biological variables in healthy and demented subjects Neuroimage. 56: 782-787. PMID 20595075 DOI: 10.1016/J.Neuroimage.2010.05.066 |
0.395 |
|
| 2009 |
Ullrich RT, Kracht L, Brunn A, Herholz K, Frommolt P, Miletic H, Deckert M, Heiss WD, Jacobs AH. Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1962-8. PMID 19910435 DOI: 10.2967/Jnumed.109.065904 |
0.344 |
|
| 2009 |
Haense C, Herholz K, Jagust WJ, Heiss WD. Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dementia and Geriatric Cognitive Disorders. 28: 259-66. PMID 19786778 DOI: 10.1159/000241879 |
0.435 |
|
| 2009 |
Markiewicz PJ, Matthews JC, Declerck J, Herholz K. Robustness of multivariate image analysis assessed by resampling techniques and applied to FDG-PET scans of patients with Alzheimer's disease Neuroimage. 46: 472-485. PMID 19385015 DOI: 10.1016/J.Neuroimage.2009.01.020 |
0.38 |
|
| 2009 |
Salmon E, Kerrouche N, Perani D, Lekeu F, Holthoff V, Beuthien-Baumann B, Sorbi S, Lemaire C, Collette F, Herholz K. On the multivariate nature of brain metabolic impairment in Alzheimer's disease. Neurobiology of Aging. 30: 186-97. PMID 17651869 DOI: 10.1016/J.Neurobiolaging.2007.06.010 |
0.45 |
|
| 2009 |
Carter S, Parker G, Ralph ML, Herholz K. Combining FDG-PET, structural MRI and probabilistic tractography in Alzheimer's disease Neuroimage. 47. DOI: 10.1016/S1053-8119(09)71032-8 |
0.69 |
|
| 2009 |
Herholz K. Imaging microvascular changes and cognitive function in dementia Journal of the Neurological Sciences. 283: 263-264. DOI: 10.1016/J.Jns.2009.02.098 |
0.343 |
|
| 2009 |
Nordberg A, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, Perani D, Almkvist O, Scheinin N, Grimmer T, Okello A, Van Laere K, Hinz R, Carter SF, Kalbe E, Herholz K. IC-S1-03: PET Amyloid imaging and cognition in patients with Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy controls: a European multicenter study Alzheimer's & Dementia. 5: P2-P2. DOI: 10.1016/J.Jalz.2009.05.006 |
0.676 |
|
| 2009 |
Herholz K, Hohmann C, Florea I, Varrone A, Haense C, Krais R, Garibotto V, Kalbe E, Bertoldo A, Perani D, Vollmar S, Heiss W. P3-081: Reduction of cortical acetylcholine esterase in mild cognitive impairment: Consistency across centers and PET methods Alzheimer's & Dementia. 5: P366-P366. DOI: 10.1016/J.Jalz.2009.04.1157 |
0.397 |
|
| 2008 |
Garibotto V, Borroni B, Kalbe E, Herholz K, Salmon E, Holtoff V, Sorbi S, Cappa SF, Padovani A, Fazio F, Perani D. Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology. 71: 1342-9. PMID 18936426 DOI: 10.1212/01.Wnl.0000327670.62378.C0 |
0.424 |
|
| 2008 |
Haense C, Buerger K, Kalbe E, Drzezga A, Teipel SJ, Markiewicz P, Herholz K, Heiss WD, Hampel H. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 15: 1155-62. PMID 18803648 DOI: 10.1111/J.1468-1331.2008.02274.X |
0.448 |
|
| 2008 |
Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G, Reiman EM, Holthoff V, Kalbe E, Sorbi S, Diehl-Schmid J, Perneczky R, Clerici F, Caselli R, Beuthien-Baumann B, et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 390-8. PMID 18287270 DOI: 10.2967/Jnumed.107.045385 |
0.499 |
|
| 2008 |
Herholz K, Weisenbach S, Kalbe E. Deficits of the cholinergic system in early AD. Neuropsychologia. 46: 1642-7. PMID 18201734 DOI: 10.1016/J.Neuropsychologia.2007.11.024 |
0.386 |
|
| 2008 |
Herholz K. Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 35: S25-9. PMID 18196237 DOI: 10.1007/S00259-007-0699-4 |
0.402 |
|
| 2008 |
Klein JC, Herholz K, Wienhard K, Heiss WD. Cortical flattening applied to high-resolution 18F-FDG PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 44-9. PMID 18077518 DOI: 10.2967/Jnumed.107.044669 |
0.398 |
|
| 2008 |
Salmon E, Perani D, Collette F, Feyers D, Kalbe E, Holthoff V, Sorbi S, Herholz K. A comparison of unawareness in frontotemporal dementia and Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 176-9. PMID 17898032 DOI: 10.1136/Jnnp.2007.122853 |
0.377 |
|
| 2008 |
Herholz K. Positron Emission Tomography Imaging in Dementia European Neurological Review. 3: 109. DOI: 10.17925/Enr.2008.03.02.109 |
0.393 |
|
| 2007 |
Herholz K, Carter SF, Jones M. Positron emission tomography imaging in dementia. The British Journal of Radiology. 80: S160-7. PMID 18445746 DOI: 10.1259/Bjr/97295129 |
0.733 |
|
| 2007 |
Coope DJ, Cízek J, Eggers C, Vollmar S, Heiss WD, Herholz K. Evaluation of primary brain tumors using 11C-methionine PET with reference to a normal methionine uptake map. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1971-80. PMID 18006617 DOI: 10.2967/Jnumed.107.043240 |
0.368 |
|
| 2007 |
Herholz K, Coope D, Jackson A. Metabolic and molecular imaging in neuro-oncology. The Lancet. Neurology. 6: 711-24. PMID 17638612 DOI: 10.1016/S1474-4422(07)70192-8 |
0.367 |
|
| 2007 |
Eggers C, Szelies B, Bauer B, Wienhard K, Schröder H, Herholz K, Heiss W. Imaging of acetylcholine esterase activity in brainstem nuclei involved in regulation of sleep and wakefulness. European Journal of Neurology. 14: 690-693. PMID 17539952 DOI: 10.1111/J.1468-1331.2007.01737.X |
0.344 |
|
| 2007 |
Herting B, Beuthien-Baumann B, Pöttrich K, Donix M, Triemer A, Lampe JB, von Kummer R, Herholz K, Reichmann H, Holthoff VA. Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 490-7. PMID 17260333 DOI: 10.1002/Mds.21237 |
0.313 |
|
| 2007 |
Herholz K. IM-06: Multicenter pet imaging Alzheimers & Dementia. 3. DOI: 10.1016/J.Jalz.2007.04.273 |
0.38 |
|
| 2006 |
Masdeu JC, Irimia P, Asenbaum S, Bogousslavsky J, Brainin M, Chabriat H, Herholz K, Markus HS, Martínez-Vila E, Niederkorn K, Schellinger PD, Seitz RJ. EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force European Journal of Neurology. 13: 1271-1283. PMID 17116208 DOI: 10.1111/J.1468-1331.2006.01507.X |
0.32 |
|
| 2006 |
Eggers C, Herholz K, Kalbe E, Heiss WD. Cortical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease. Neuroscience Letters. 408: 46-50. PMID 16996687 DOI: 10.1016/J.Neulet.2006.08.061 |
0.439 |
|
| 2006 |
Herholz K. Cognitive dysfunction and emotional-behavioural changes in MS: the potential of positron emission tomography. Journal of the Neurological Sciences. 245: 9-13. PMID 16626746 DOI: 10.1016/J.Jns.2005.09.012 |
0.459 |
|
| 2006 |
Peters F, Perani D, Herholz K, Holthoff V, Beuthien-Baumann B, Sorbi S, Pupi A, Degueldre C, Lemaire C, Collette F, Salmon E. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dementia and Geriatric Cognitive Disorders. 21: 373-9. PMID 16534207 DOI: 10.1159/000091898 |
0.331 |
|
| 2006 |
Kerrouche N, Herholz K, Mielke R, Holthoff V, Baron JC. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 26: 1213-21. PMID 16525414 DOI: 10.1038/Sj.Jcbfm.9600296 |
0.471 |
|
| 2006 |
Galldiks N, Kracht LW, Burghaus L, Thomas A, Jacobs AH, Heiss WD, Herholz K. Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. European Journal of Nuclear Medicine and Molecular Imaging. 33: 516-24. PMID 16450140 DOI: 10.1007/S00259-005-0002-5 |
0.405 |
|
| 2006 |
Salmon E, Kerrouche N, Herholz K, Perani D, Holthoff V, Beuthien-Baumann B, Degueldre C, Lemaire C, Luxen A, Baron JC, Collette F, Garraux G. Decomposition of metabolic brain clusters in the frontal variant of frontotemporal dementia. Neuroimage. 30: 871-8. PMID 16359874 DOI: 10.1016/J.Neuroimage.2005.10.016 |
0.39 |
|
| 2006 |
Salmon E, Perani D, Herholz K, Marique P, Kalbe E, Holthoff V, Delbeuck X, Beuthien-Baumann B, Pelati O, Lespagnard S, Collette F, Garraux G. Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease. Human Brain Mapping. 27: 588-97. PMID 16247783 DOI: 10.1002/Hbm.20203 |
0.434 |
|
| 2006 |
Heiss W, Hänse C, Herholz K. Mild Cognitive Impairment - A Preclinical State of Alzheimer’s Disease? European Neurological Review. 68. DOI: 10.17925/Enr.2006.00.02.68 |
0.327 |
|
| 2006 |
Galldiks N, Kracht LW, Burghaus L, Ullrich R, Kesper K, Heiss WD, Herholz K, Jacobs AH, Haupt WF. PET guided chemotherapy – monitoring metabolic effects of temozolomide chemotherapy in malignant gliomas and of long-term adjuvant chemotherapy in patients with glioblastoma Aktuelle Neurologie. 33: 361. DOI: 10.1055/S-2006-953186 |
0.308 |
|
| 2006 |
HERHOLZ K, NORDBERG A, MASDEU J, GERHARD A, EBMEIER K, PAPPATA S, PERANI D, VANLAERE K, HALLDIN C, SALMON E. Imaging of Neurotransmitter Deficits: New Potential Biomarkers for Alzheimer’s Disease? Neurorx. 3: 412-412. DOI: 10.1016/J.Nurx.2006.05.026 |
0.478 |
|
| 2006 |
Herholz K, Weisenbach S, Hilker R, Heiss W. Measuring Cortical Acetylcholine Esterase Activity by PET in Dementia: Clinical Correlates Neurorx. 3: 410-410. DOI: 10.1016/J.Nurx.2006.05.020 |
0.398 |
|
| 2006 |
Eggers C, Herholz K, Kalbe E, Heiss WD. P1-198: Cortical acetylcholine esterase activity, glucose metabolism, and ApoE4-genotype in Alzheimer disease: A PET study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.573 |
0.428 |
|
| 2005 |
Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L, Jacobs AH, Herholz K, Heiss WD. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology. 65: 1716-22. PMID 16344512 DOI: 10.1212/01.Wnl.0000191154.78131.F6 |
0.359 |
|
| 2005 |
Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, ... ... Herholz K, et al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Archives of Neurology. 62: 1728-33. PMID 16286547 DOI: 10.1001/Archneur.62.11.1728 |
0.504 |
|
| 2005 |
Salmon E, Lespagnard S, Marique P, Peeters F, Herholz K, Perani D, Holthoff V, Kalbe E, Anchisi D, Adam S, Collette F, Garraux G. Cerebral metabolic correlates of four dementia scales in Alzheimer's disease Journal of Neurology. 252: 283-290. PMID 16189724 DOI: 10.1007/S00415-005-0551-3 |
0.448 |
|
| 2005 |
Herholz K, Weisenbach S, Kalbe E, Diederich NJ, Heiss WD. Cerebral acetylcholine esterase activity in mild cognitive impairment. Neuroreport. 16: 1431-4. PMID 16110265 DOI: 10.1097/01.Wnr.0000177007.21732.7B |
0.43 |
|
| 2005 |
Hilker R, Portman AT, Voges J, Staal MJ, Burghaus L, van Laar T, Koulousakis A, Maguire RP, Pruim J, de Jong BM, Herholz K, Sturm V, Heiss WD, Leenders KL. Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1217-21. PMID 16107354 DOI: 10.1136/Jnnp.2004.057893 |
0.347 |
|
| 2005 |
Lange C, Kracht L, Herholz K, Sachsse U, Irle E. Reduced glucose metabolism in temporo-parietal cortices of women with borderline personality disorder. Psychiatry Research. 139: 115-26. PMID 15978784 DOI: 10.1016/J.Pscychresns.2005.05.003 |
0.353 |
|
| 2005 |
Sobesky J, Thiel A, Ghaemi M, Hilker RH, Rudolf J, Jacobs AH, Herholz K, Heiss WD. Crossed cerebellar diaschisis in acute human stroke: a PET study of serial changes and response to supratentorial reperfusion. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 1685-91. PMID 15931159 DOI: 10.1038/Sj.Jcbfm.9600162 |
0.314 |
|
| 2005 |
Jacobs AH, Kracht LW, Gossmann A, Rüger MA, Thomas AV, Thiel A, Herholz K. Imaging in neurooncology. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 2: 333-47. PMID 15897954 DOI: 10.1602/Neurorx.2.2.333 |
0.327 |
|
| 2005 |
Kalbe E, Salmon E, Perani D, Holthoff V, Sorbi S, Elsner A, Weisenbach S, Brand M, Lenz O, Kessler J, Luedecke S, Ortelli P, Herholz K. Anosognosia in very mild Alzheimer's disease but not in mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 19: 349-56. PMID 15802909 DOI: 10.1159/000084704 |
0.381 |
|
| 2005 |
Hilker R, Schweitzer K, Coburger S, Ghaemi M, Weisenbach S, Jacobs AH, Rudolf J, Herholz K, Heiss WD. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Archives of Neurology. 62: 378-82. PMID 15767502 DOI: 10.1001/Archneur.62.3.378 |
0.361 |
|
| 2005 |
Herholz K. Action of cholinesterase inhibitors in patients’ brains Journal of Neurology, Neurosurgery, and Psychiatry. 76: 305-305. PMID 15716515 DOI: 10.1136/Jnnp.2004.048405 |
0.387 |
|
| 2005 |
Holthoff VA, Beuthien-Baumann B, Kalbe E, Lüdecke S, Lenz O, Zündorf G, Spirling S, Schierz K, Winiecki P, Sorbi S, Herholz K. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biological Psychiatry. 57: 412-21. PMID 15705358 DOI: 10.1016/J.Biopsych.2004.11.035 |
0.448 |
|
| 2005 |
Mosconi L, Herholz K, Prohovnik I, Nacmias B, De Cristofaro MT, Fayyaz M, Bracco L, Sorbi S, Pupi A. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 15-23. PMID 15607989 DOI: 10.1136/Jnnp.2003.030882 |
0.436 |
|
| 2005 |
Hilker R, Portman A, Voges J, Staal M, Burghaus L, van Laar T, Koulousakis A, Maguire R, Pruim J, Herholz K, de Jong B, Sturm V, Heiss W, Leenders K. Erkrankungsprogression bei Patienten mit idiopathischem Parkinson-Syndrom und STN-Stimulation – Eine 18-Fluorodopa-PET-Verlaufsstudie Aktuelle Neurologie. 32. DOI: 10.1055/S-2005-866691 |
0.339 |
|
| 2005 |
Herholz K, Wienhard K, Cizek J, Thiel A, Vollmar S, Klein J, Heiss W. Glucose metabolism in distinct human midbrain nuclei and correlations with other brain regions Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0618 |
0.321 |
|
| 2005 |
Klein JC, Lennartz D, Poggenborg J, Herholz K, Lackner K, Sturm V, Heiss WD. Mechanisms of deep brain stimulation in obsessive-compulsive disorder revealed by 15O-H2O PET and diffusion tractography Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0315 |
0.3 |
|
| 2004 |
Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, Salmon E, Baron JC, De Cristofaro MT, Padovani A, Borroni B, Franceschi M, Bracco L, Pupi A. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology. 63: 2332-40. PMID 15623696 DOI: 10.1212/01.Wnl.0000147469.18313.3B |
0.436 |
|
| 2004 |
Kracht LW, Miletic H, Busch S, Jacobs AH, Voges J, Hoevels M, Klein JC, Herholz K, Heiss WD. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7163-70. PMID 15534088 DOI: 10.1158/1078-0432.Ccr-04-0262 |
0.336 |
|
| 2004 |
Galldiks N, Burghaus L, Vollmar S, Cizek J, Impekoven P, Thomas A, Jacobs AH, Herholz K. Novel neuroimaging findings in a patient with cerebral Whipple's disease: a magnetic resonance imaging and positron emission tomography study. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 14: 372-6. PMID 15358961 DOI: 10.1177/1051228404267994 |
0.416 |
|
| 2004 |
Holthoff VA, Beuthien-Baumann B, Zündorf G, Triemer A, Ludecke S, Winiecki P, Koch R, Fuchtner F, Herholz K. Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatrica Scandinavica. 110: 184-194. PMID 15283738 DOI: 10.1111/J.1600-0447.2004.00351.X |
0.373 |
|
| 2004 |
Herholz K, Heiss WD. Positron emission tomography in clinical neurology. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 6: 239-69. PMID 15262239 DOI: 10.1016/J.Mibio.2004.05.002 |
0.451 |
|
| 2004 |
Cízek J, Herholz K, Vollmar S, Schrader R, Klein J, Heiss WD. Fast and robust registration of PET and MR images of human brain. Neuroimage. 22: 434-42. PMID 15110036 DOI: 10.1016/J.Neuroimage.2004.01.016 |
0.352 |
|
| 2004 |
Mosconi L, Sorbi S, Nacmias B, De Cristofaro MT, Fayyaz M, Bracco L, Herholz K, Pupi A. Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study. Psychiatry Research. 130: 141-51. PMID 15033184 DOI: 10.1016/J.Pscychresns.2003.12.005 |
0.46 |
|
| 2004 |
Mosconi L, Pupi A, De Cristofaro MT, Fayyaz M, Sorbi S, Herholz K. Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 45: 382-92. PMID 15001677 |
0.403 |
|
| 2004 |
Mosconi L, Nacmias B, Sorbi S, De Cristofaro MT, Fayazz M, Tedde A, Bracco L, Herholz K, Pupi A. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 370-6. PMID 14966149 DOI: 10.1136/Jnnp.2003.014993 |
0.436 |
|
| 2004 |
Herholz K, Weisenbach S, Zündorf G, Lenz O, Schröder H, Bauer B, Kalbe E, Heiss W. In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease. Neuroimage. 21: 136-143. PMID 14741650 DOI: 10.1016/J.Neuroimage.2003.09.042 |
0.452 |
|
| 2004 |
Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, Lehrke R, Koulousakis A, Herholz K, Sturm V, Heiss WD. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 24: 7-16. PMID 14688612 DOI: 10.1097/01.Wcb.0000092831.44769.09 |
0.377 |
|
| 2004 |
Herholz K, Weisenbach S, Kalbe E, Heiss W. P2-169 Pet imaging of cerebral acetylcholine esterase activity in mild cognitive impairment Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80916-3 |
0.417 |
|
| 2004 |
Mosconi L, Pupi A, Sorbi S, Holthoff V, Perani D, Salmon E, Baron JC, Nacmias B, Piccini C, Bracco L, Herholz K. P2-152 Basal frontal/temporal hypometabolism and depressive symptoms in highly educated Alzheimer's disease patients Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80899-6 |
0.303 |
|
| 2004 |
Herholz K. S3-03-04 Standardization of pet in diagnosis of Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80166-0 |
0.417 |
|
| 2003 |
Thiel A, Hilker R, Kessler J, Habedank B, Herholz K, Heiss W. Activation of basal ganglia loops in idiopathic Parkinson’s disease: a PET study Journal of Neural Transmission. 110: 1289-1301. PMID 14628193 DOI: 10.1007/S00702-003-0041-7 |
0.382 |
|
| 2003 |
Heiss W, Thiel A, Kessler J, Herholz K. Disturbance and recovery of language function: correlates in PET activation studies. Neuroimage. 20. PMID 14597295 DOI: 10.1016/J.Neuroimage.2003.09.005 |
0.302 |
|
| 2003 |
Mosconi L, Sorbi S, Nacmias B, De Cristofaro MT, Fayyaz M, Cellini E, Bagnoli S, Bracco L, Herholz K, Pupi A. Brain metabolic differences between sporadic and familial Alzheimer's disease. Neurology. 61: 1138-40. PMID 14581683 DOI: 10.1212/01.Wnl.0000086816.30011.75 |
0.442 |
|
| 2003 |
Salmon E, Garraux G, Delbeuck X, Collette F, Kalbe E, Zuendorf G, Perani D, Fazio F, Herholz K. Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia. Neuroimage. 20: 435-40. PMID 14527604 DOI: 10.1016/S1053-8119(03)00346-X |
0.433 |
|
| 2003 |
Heiss WD, Thiel A, Winhuisen L, Mühlberger B, Kessler J, Herholz K. Functional imaging in the assessment of capability for recovery after stroke. Journal of Rehabilitation Medicine. 27-33. PMID 12817654 DOI: 10.1080/16501960310010115 |
0.315 |
|
| 2003 |
Herholz K. PET studies in dementia. Annals of Nuclear Medicine. 17: 79-89. PMID 12790355 DOI: 10.1007/Bf02988444 |
0.525 |
|
| 2003 |
Jacobs AH, Li H, Winkeler A, Hilker R, Knoess C, Rüger A, Galldiks N, Schaller B, Sobesky J, Kracht L, Monfared P, Klein M, Vollmar S, Bauer B, Wagner R, ... ... Herholz K, et al. PET-based molecular imaging in neuroscience. European Journal of Nuclear Medicine and Molecular Imaging. 30: 1051-65. PMID 12764552 DOI: 10.1007/S00259-003-1202-5 |
0.368 |
|
| 2003 |
Kracht LW, Friese M, Herholz K, Schroeder R, Bauer B, Jacobs A, Heiss WD. Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. European Journal of Nuclear Medicine and Molecular Imaging. 30: 868-73. PMID 12692687 DOI: 10.1007/S00259-003-1148-7 |
0.371 |
|
| 2003 |
Zuendorf G, Kerrouche N, Herholz K, Baron JC. Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging. Human Brain Mapping. 18: 13-21. PMID 12454908 DOI: 10.1002/Hbm.10069 |
0.374 |
|
| 2003 |
Herholz K, Kracht LW, Heiss W. Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET Journal of Neuroimaging. 13: 269-271. DOI: 10.1111/J.1552-6569.2003.Tb00190.X |
0.379 |
|
| 2002 |
Jacobs AH, Winkler A, Dittmar C, Gossman A, Deckert M, Kracht L, Thiel A, Garlip G, Hilker R, Sobesky J, Vollmar S, Kummer C, Graf R, Voges J, Wienhard K, ... Herholz K, et al. Molecular and functional imaging technology for the development of efficient treatment strategies for gliomas. Technology in Cancer Research & Treatment. 1: 187-204. PMID 12622512 DOI: 10.1177/153303460200100304 |
0.395 |
|
| 2002 |
Heiss W, Thiel A, Kessler J, Herholz K. Sprachaktivierung im PET bei ischaemischen Insulten und Hirntumoren Zentralblatt FüR Neurochirurgie. 63: 133-140. PMID 12518255 DOI: 10.1055/S-2002-36435 |
0.352 |
|
| 2002 |
Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L, Schönknecht P, Ito K, Mielke R, Kalbe E, Zündorf G, Delbeuck X, Pelati O, Anchisi D, Fazio F, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 17: 302-16. PMID 12482085 DOI: 10.1006/Nimg.2002.1208 |
0.475 |
|
| 2002 |
Hilker R, Voges J, Thiel A, Ghaemi M, Herholz K, Sturm V, Heiss WD. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET. Journal of Neural Transmission. 109: 1257-1264. PMID 12373559 DOI: 10.1007/S00702-002-0696-5 |
0.38 |
|
| 2002 |
Szelies B, Sobesky J, Pawlik G, Mielke R, Bauer B, Herholz K, Heiss W. Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by [(11)C]-flumazenil PET. European Journal of Neurology. 9: 137-142. PMID 11882054 DOI: 10.1046/J.1468-1331.2002.00338.X |
0.301 |
|
| 2002 |
Herholz K, Schopphoff H, Schmidt M, Mielke R, Eschner W, Scheidhauer K, Schicha H, Heiss WD, Ebmeier K. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 21-6. PMID 11801698 |
0.387 |
|
| 2001 |
Jauss M, Herholz K, Kracht L, Pantel J, Hartmann T, Jensen M, Essig M, Schröder J. Frontotemporal dementia: clinical, neuroimaging, and molecular biological findings in 6 patients. European Archives of Psychiatry and Clinical Neuroscience. 251: 225-31. PMID 11829209 DOI: 10.1007/S004060170031 |
0.439 |
|
| 2001 |
Thiel A, Herholz K, Koyuncu A, Ghaemi M, Kracht LW, Habedank B, Heiss WD. Plasticity of language networks in patients with brain tumors: A positron emission tomography activation study Annals of Neurology. 50: 620-629. PMID 11706968 DOI: 10.1002/Ana.1253 |
0.323 |
|
| 2001 |
Herholz K, Lercher M, Wienhard K, Bauer B, Lenz O, Heiss WD. PET measurement of cerebral acetylcholine esterase activity without blood sampling. European Journal of Nuclear Medicine. 28: 472-7. PMID 11357497 DOI: 10.1007/S002590100492 |
0.313 |
|
| 2001 |
Ghaemi M, Rudolf J, Hilker R, Herholz K, Heiss W. Increased pineal Fdopa uptake is related to severity of Parkinson's disease - a PET study Journal of Pineal Research. 30: 213-219. PMID 11339510 DOI: 10.1034/J.1600-079X.2001.300404.X |
0.328 |
|
| 2001 |
Herholz K, Perani D, Fazekas F, Markus H, Baumgartner RW, Baron J‐. A survey of neuroimaging research in European neurological departments. European Journal of Neurology. 8: 111-117. PMID 11284990 DOI: 10.1046/J.1468-1331.2001.00206.X |
0.395 |
|
| 2001 |
Herholz K, Ehlen P, Kessler J, Strotmann T, Kalbe E, Markowitsch HJ. Learning face-name associations and the effect of age and performance: a PET activation study. Neuropsychologia. 39: 643-50. PMID 11257289 DOI: 10.1016/S0028-3932(00)00144-5 |
0.324 |
|
| 2001 |
Huber M, Siol T, Herholz K, Lenz O, Köhle K, Heiss WD. Activation of Thalamo-Cortical Systems in Post-Traumatic Flashbacks: A Positron Emission Tomography Study Traumatology. 7: 131-141. DOI: 10.1177/153476560100700402 |
0.302 |
|
| 2001 |
Ebmeier K, Prohovnik I, Pupi A, Rodriguez G, Nobili F, Migneco O, Koulibali M, Herholz K, Scheidhauer K, Glabus M. Using SPM as a diagnostic help with HMPAO-SPECT in Alzheimer's disease Neuroimage. 13: 1044. DOI: 10.1016/S1053-8119(01)90010-2 |
0.369 |
|
| 2001 |
Hilker R, Klein C, Ghaemi M, Kis B, Strotmann T, Ozelius LJ, Lenz O, Vieregge P, Herholz K, Heiss WD, Pramstaller PP. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial Parkinsonism associated with mutations in the Parkin gene Annals of Neurology. 49: 367-376. DOI: 10.1002/Ana.74 |
0.33 |
|
| 2000 |
Herholz K, Bauer B, Wienhard K, Kracht L, Mielke R, Lenz O, Strotmann T, Heiss W-. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism Journal of Neural Transmission. 107: 1457-1468. PMID 11458998 DOI: 10.1007/S007020070009 |
0.437 |
|
| 2000 |
Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, Pruim J, Price P. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. European Journal of Cancer (Oxford, England : 1990). 35: 1773-82. PMID 10673991 DOI: 10.1016/S0959-8049(99)00229-4 |
0.388 |
|
| 2000 |
Muzik O, da Silva EA, Juhasz C, Chugani DC, Shah J, Nagy F, Canady A, von Stockhausen HM, Herholz K, Gates J, Frost M, Ritter F, Watson C, Chugani HT. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology. 54: 171-9. PMID 10636144 DOI: 10.1212/Wnl.54.1.171 |
0.413 |
|
| 2000 |
Thiel A, Pietrzyk U, Sturm V, Herholz K, Hövels M, Schröder R. Enhanced Accuracy in Differential Diagnosis of Radiation Necrosis by Positron Emission Tomography-Magnetic Resonance Imaging Coregistration: Technical Case Report Neurosurgery. 46: 232-234. DOI: 10.1093/Neurosurgery/46.1.232 |
0.363 |
|
| 1999 |
Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, Halber M, Jelic V, Almkvist O, Collette F, Alberoni M, Kennedy A, Hasselbalch S, Fazio F, Heiss WD. Impairment of neocortical metabolism predicts progression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 10: 494-504. PMID 10559566 DOI: 10.1159/000017196 |
0.46 |
|
| 1999 |
Kracht LW, Bauer A, Herholz K, Terstegge K, Friese M, Schröder R, Heiss W. Positron emission tomography in a case of intracranial hemangiopericytoma. Journal of Computer Assisted Tomography. 23: 365-368. PMID 10348440 DOI: 10.1097/00004728-199905000-00008 |
0.389 |
|
| 1999 |
Hageman G, van der Hoek J, van Hout M, van der Laan G, Steur EJ, de Bruin W, Herholz K. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. Journal of Neurology. 246: 198-206. PMID 10323318 DOI: 10.1007/S004150050334 |
0.35 |
|
| 1998 |
Kuwert T, Bartenstein P, Grünwald F, Herholz K, Larisch R, Sabri O, Biersack H-, Moser E, Müller-Gärtner H-, Schober O, Schwaiger M, Büll U, Heiss W-. Klinische Wertigkeit der Positronen-Emissions-Tomographie in der NeuromedizinPositionspapier zu den Ergebnissen einer interdisziplinären Konsensuskonferenz Nervenarzt. 69: 1045-1060. PMID 9888141 DOI: 10.1007/S001150050382 |
0.306 |
|
| 1998 |
Mielke R, Kessler J, Szelies B, Herholz K, Wienhard K, Heiss W-. Normal and pathological aging – findings of positron-emission-tomography Journal of Neural Transmission. 105: 821-837. PMID 9869321 DOI: 10.1007/S007020050097 |
0.461 |
|
| 1998 |
Karbe H, Herholz K, Halber M, Heiss W. Collateral Inhibition of Transcallosal Activity Facilitates Functional Brain Asymmetry Journal of Cerebral Blood Flow and Metabolism. 18: 1157-1161. PMID 9778192 DOI: 10.1097/00004647-199810000-00012 |
0.371 |
|
| 1998 |
Karbe H, Thiel A, Weber-Luxenburger G, Herholz K, Kessler J, Heiss W. Brain plasticity in poststroke aphasia: what is the contribution of the right hemisphere? Brain and Language. 64: 215-230. PMID 9710490 DOI: 10.1006/Brln.1998.1961 |
0.353 |
|
| 1998 |
Karbe H, Herholz K, Weber-Luxenburger G, Ghaemi M, Heiss W. Cerebral networks and functional brain asymmetry: evidence from regional metabolic changes during word repetition. Brain and Language. 63: 108-121. PMID 9642023 DOI: 10.1006/Brln.1997.1937 |
0.366 |
|
| 1998 |
Thiel A, Herholz K, Stockhausen Hv, Leyen-Pilgram Kv, Pietrzyk U, Kessler J, Wienhard K, Klug N, Heiss W. Localization of Language-Related Cortex with15O-Labeled Water PET in Patients with Gliomas Neuroimage. 7: 284-295. PMID 9626669 DOI: 10.1006/Nimg.1998.0334 |
0.342 |
|
| 1998 |
Herholz K, Hölzer T, Bauer B, Schröder R, Voges J, Ernestus RI, Mendoza G, Weber-Luxenburger G, Löttgen J, Thiel A, Wienhard K, Heiss WD. 11C-methionine PET for differential diagnosis of low-grade gliomas Neurology. 50: 1316-1322. PMID 9595980 DOI: 10.1212/Wnl.50.5.1316 |
0.344 |
|
| 1998 |
Mielke R, Ghaemi M, Kessler J, Kittner B, Szelies B, Herholz K, Heiss W-. Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's disease Journal of the Neurological Sciences. 154: 76-82. PMID 9543326 DOI: 10.1016/S0022-510X(97)00217-7 |
0.422 |
|
| 1997 |
Herholz K. Diagnostic imaging of dementia in the elderly Archives of Gerontology and Geriatrics. 25: 5-12. PMID 15374097 DOI: 10.1016/S0167-4943(96)00767-4 |
0.44 |
|
| 1997 |
Voges J, Herholz K, Holzer T, Wurker M, Bauer B, Pietrzyk U, Treuer H, Schroder R, Sturm V, Heiss WD. 11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: A tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds Stereotactic and Functional Neurosurgery. 69: 129-135. PMID 9711745 DOI: 10.1159/000099864 |
0.443 |
|
| 1997 |
Halber M, Herholz K, Wienhard K, Pawlik G, Heiss W. Performance of a Randomization Test for Single-Subject 15O-Water PET Activation Studies Journal of Cerebral Blood Flow and Metabolism. 17: 1033-1039. PMID 9346427 DOI: 10.1097/00004647-199710000-00004 |
0.336 |
|
| 1997 |
Heiss W, Karbe H, Weber-Luxenburger G, Herholz K, Kessler J, Pietrzyk U, Pawlik G. Speech-induced cerebral metabolic activation reflects recovery from aphasia Journal of the Neurological Sciences. 145: 213-217. PMID 9094051 DOI: 10.1016/S0022-510X(96)00252-3 |
0.333 |
|
| 1997 |
Holthoff-Detto VA, Kessler J, Herholz K, Bönner H, Pietrzyk U, Würker M, Ghaemi M, Wienhard K, Wagner R, Heiss W. Functional Effects of Striatal Dysfunction in Parkinson Disease Jama Neurology. 54: 145-150. PMID 9041855 DOI: 10.1001/Archneur.1997.00550140025008 |
0.413 |
|
| 1997 |
Herholz K. Pet Evaluation of Drugs in Alzheimer's and Parkinson's Diseases Drug Information Journal. 31: 1035-1044. DOI: 10.1177/009286159703100348 |
0.434 |
|
| 1996 |
Herholz K, Thiel A, Wienhard K, Pietrzyk U, Stockhausen HMv, Karbe H, Kessler J, Bruckbauer T, Halber M, Heiss WD. Individual Functional Anatomy of Verb Generation Neuroimage. 3: 185-194. PMID 9345489 DOI: 10.1006/Nimg.1996.0020 |
0.34 |
|
| 1996 |
Szelies B, Weber-Luxenburger G, Pawlik G, Kessler J, Holthoff V, Mielke R, Herholz K, Bauer B, Wienhard K, Heiss W-. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage. 3: 109-118. PMID 9345482 DOI: 10.1006/Nimg.1996.0013 |
0.448 |
|
| 1996 |
Mielke R, Kittner B, Ghaemi M, Kessler J, Szelies B, Herholz K, Heiss W-. Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementia Journal of the Neurological Sciences. 141: 59-64. PMID 8880694 DOI: 10.1016/0022-510X(96)00127-X |
0.431 |
|
| 1996 |
Mielke R, Kessler J, Szelies B, Herholz K, Wienhard K, Heiss W-. Vascular dementia: perfusional and metabolic disturbances and effects of therapy Journal of Neural Transmission-Supplement. 47: 183-191. PMID 8841965 DOI: 10.1007/978-3-7091-6892-9_12 |
0.502 |
|
| 1996 |
Mielke R, Schröder R, Fink GR, Kessler J, Herholz K, Heiss WD. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathologica. 91: 174-179. PMID 8787151 DOI: 10.1007/S004010050410 |
0.489 |
|
| 1996 |
Pietrzyk U, Herholz K, Schuster A, Stockhausen Hv, Lucht H, Heiss W. Clinical applications of registration and fusion of multimodality brain images from PET, SPECT, CT, and MRI European Journal of Radiology. 21: 174-182. PMID 8777907 DOI: 10.1016/0720-048X(95)00713-Z |
0.362 |
|
| 1996 |
Jacobs A, Herholz K, Pietrzyk U, Würker M, Wienhard K, Heiss WD. Diaschisis of specific cerebellar lobules: pontine haematoma studied with high-resolution PET and MRI. Journal of Neurology. 243: 131-136. PMID 8750549 DOI: 10.1007/Bf02444003 |
0.395 |
|
| 1996 |
Herholz K. Neuroimaging in anorexia nervosa Psychiatry Research-Neuroimaging. 62: 105-110. PMID 8739120 DOI: 10.1016/0165-1781(96)02990-3 |
0.403 |
|
| 1996 |
Würker M, Herholz K, Voges J, Pietrzyk U, Treuer H, Bauer B, Sturm V, Heiss WD. Glucose consumption and methionine uptake in low-grade gliomas after iodine-125 brachytherapy. European Journal of Nuclear Medicine and Molecular Imaging. 23: 583-586. PMID 8698067 DOI: 10.1007/Bf00833397 |
0.379 |
|
| 1996 |
Kessler J, Ghaemi M, Mielke R, Herholz K, Heiss WD. Visual versus Auditory Memory Stimulation in Patients with Probable Alzheimer's Disease A PET Study with 18 FDGa Annals of the New York Academy of Sciences. 777: 233-238. PMID 8624090 DOI: 10.1111/J.1749-6632.1996.Tb34424.X |
0.364 |
|
| 1996 |
Halber M, Herholz K, Wienhard K, Pawlik G, Heiss W. Permutation test analysis of functional 15O-H2O-PET brain images: Application to single-subject speech activation studies Neuroimage. 3. DOI: 10.1016/S1053-8119(96)80065-6 |
0.346 |
|
| 1996 |
Mielke R, Ghaemi M, Kittner B, Kessler J, Herholz K, Heiss W-. 613 Propentofylline enhances brain activation during memory stimulation in Alzheimer's disease — a PET study with 18-FDG Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80615-4 |
0.427 |
|
| 1995 |
Karbe H, Kessler J, Herholz K, Fink GR, Heiss WD. Long-term prognosis of poststroke aphasia studied with positron emission tomography. Archives of Neurology. 52: 186-90. PMID 7848129 DOI: 10.1001/Archneur.1995.00540260092022 |
0.324 |
|
| 1995 |
Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, Herholz K, Heiss WD. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. European Journal of Nuclear Medicine. 21: 1052-60. PMID 7828614 DOI: 10.1007/Bf00181059 |
0.503 |
|
| 1995 |
Lanfermann H, Kugel H, Heindel W, Herholz K, Heiss WD, Lackner K. Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. Radiology. 196: 203-210. PMID 7784568 DOI: 10.1148/Radiology.196.1.7784568 |
0.303 |
|
| 1995 |
Duncan DB, Herholz K, Kugel H, Roth B, Ruitenbeek W, Heindel W, Wienhard K, Heiss W‐. Positron emission tomography and magnetic resonance spectroscopy of cerebral glycolysis in children with congenital lactic acidosis Annals of Neurology. 37: 351-358. PMID 7695234 DOI: 10.1002/Ana.410370311 |
0.361 |
|
| 1995 |
Slansky I, Herholz K, Pietrzyk U, Kessler J, Grond M, Mielke R, Heiss WD. Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism Neuroradiology. 37: 270-277. PMID 7666958 DOI: 10.1007/Bf00588331 |
0.477 |
|
| 1995 |
Karbe H, Würker M, Herholz K, Ghaemi M, Pietrzyk U, Kessler J, Heiss W. Planum Temporale and Brodmann's Area 22: Magnetic Resonance Imaging and High-Resolution Positron Emission Tomography Demonstrate Functional Left-Right Asymmetry Jama Neurology. 52: 869-874. PMID 7661723 DOI: 10.1001/Archneur.1995.00540330047013 |
0.381 |
|
| 1995 |
Duncan DB, Herholz K, Pietrzyk U, Heiss W. Regional cerebral blood flow and metabolism in Sturge-Weber disease. Clinical Nuclear Medicine. 20: 522-523. PMID 7648737 DOI: 10.1097/00003072-199506000-00012 |
0.355 |
|
| 1995 |
Herholz K. FDG PET and differential diagnosis of dementia. Alzheimer Disease & Associated Disorders. 9: 6-16. PMID 7605624 DOI: 10.1097/00002093-199505000-00004 |
0.492 |
|
| 1995 |
Mielke R, Kessler J, Fink G, Herholz K, Heiss WD. Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease. The International Journal of Neuroscience. 82: 1-9. PMID 7591506 DOI: 10.3109/00207459508994285 |
0.349 |
|
| 1995 |
Rosenow F, Herholz K, Lanfermann H, Weuthen G, Ebner R, Kessler J, Ghaemi M, Heiss WD. Neurological sequelae of cyanide intoxication--the patterns of clinical, magnetic resonance imaging, and positron emission tomography findings. Annals of Neurology. 38: 825-8. PMID 7486875 DOI: 10.1002/Ana.410380518 |
0.389 |
|
| 1995 |
Duncan DB, Herholz K, Kugel H, Roth B, Ruitenbeek W, Heindel W, Wienhard K, Heiss WD. Pet And Mrs Of Cerebral Glycolysis In Children With Congenital Lactic Acidosis Clinical Nuclear Medicine. 20: 475. DOI: 10.1097/00003072-199505000-00034 |
0.343 |
|
| 1994 |
Huber M, Hojer C, Neveling M, Fink GR, Herholz K. Transcranial doppler and 15O-H2O-positron emission tomography findings in patients with acute brain infarction and middle cerebral artery stenosis Journal of Stroke & Cerebrovascular Diseases. 4: 23-29. PMID 26487531 DOI: 10.1016/S1052-3057(10)80142-9 |
0.351 |
|
| 1994 |
Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Clinical Deterioration in Probable Alzheimer's Disease Correlates with Progressive Metabolic Impairment of Association Areas Dementia and Geriatric Cognitive Disorders. 5: 36-41. PMID 8156085 DOI: 10.1159/000106692 |
0.445 |
|
| 1994 |
Ichimiya A, Herholz K, Mielke R, Kessler J, Slansky I, Heiss WD. Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study. Journal of the Neurological Sciences. 123: 11-17. PMID 8064302 DOI: 10.1016/0022-510X(94)90197-X |
0.394 |
|
| 1994 |
Heiss W, Herholz K. Assessment of pathophysiology of stroke by positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 21: 455-465. PMID 8062853 DOI: 10.1007/Bf00171424 |
0.366 |
|
| 1994 |
Holthoff VA, Vieregge P, Kessler J, Pietrzyk U, Herholz K, Bönner J, Wagner R, Wienhard K, Pawlik G, Heiss W‐. Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits Annals of Neurology. 36: 176-182. PMID 8053653 DOI: 10.1002/Ana.410360209 |
0.418 |
|
| 1994 |
Heiss W-, Kessler J, Mielke R, Szelies B, Herholz K. Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease: a neuropsychological, EEG, and PET investigation Dementia. 5: 88-98. PMID 8038871 DOI: 10.1159/000106702 |
0.399 |
|
| 1994 |
Herholz K, Pietrzyk U, Karbe H, Würker M, Wienhard K, Heiss W-. Individual metabolic anatomy of repeating words demonstrated by MRI-guided positron emission tomography Neuroscience Letters. 182: 47-50. PMID 7891885 DOI: 10.1016/0304-3940(94)90202-X |
0.408 |
|
| 1994 |
Szelies B, Mielke R, Herholz K, Heiss W-. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia Electroencephalography and Clinical Neurophysiology. 91: 131-139. PMID 7519142 DOI: 10.1016/0013-4694(94)90034-5 |
0.455 |
|
| 1993 |
Fink GR, Herholz K, Pietrzyk U, Huber M, Heiss W. Peri-Infarct perfusion in human ischemia: Its relation to tissue metabolism, morphology, and clinical outcome Journal of Stroke & Cerebrovascular Diseases. 3: 123-131. PMID 26487259 DOI: 10.1016/S1052-3057(10)80239-3 |
0.363 |
|
| 1993 |
Mielke R, Herholz K, Fink G, Ritter D, Heiss WD. Positron emission tomography in myotonic dystrophy. Psychiatry Research. 50: 93-9. PMID 8378492 DOI: 10.1016/0925-4927(93)90014-9 |
0.434 |
|
| 1993 |
Holzer T, Herholz K, Jeske J, Heiss WD. Fdg-pet as a prognostic indicator in radiochemotherapy of glioblastoma Journal of Computer Assisted Tomography. 17: 681-687. PMID 8370819 DOI: 10.1097/00004728-199309000-00002 |
0.391 |
|
| 1993 |
Holthoff VA, Herholz K, Berthold F, Widemann B, Schröder R, Neubauer I, Heiss WD. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment. Cancer. 72: 1394-1403. PMID 8339230 DOI: 10.1002/1097-0142(19930815)72:4<1394::Aid-Cncr2820720440>3.0.Co;2-D |
0.382 |
|
| 1993 |
Heiss WD, Emunds HG, Herholz K. Cerebral glucose metabolism as a predictor of rehabilitation after ischemic stroke. Stroke. 24: 1784-1788. PMID 8248955 DOI: 10.1161/01.Str.24.12.1784 |
0.328 |
|
| 1993 |
Herholz K, Pietrzyk U, Voges J, Schröder R, Halber M, Treuer H, Sturm V, Heiss W. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. Journal of Neurosurgery. 79: 853-858. PMID 8246053 DOI: 10.3171/Jns.1993.79.6.0853 |
0.384 |
|
| 1993 |
Heiss WD, Kessler J, Slansky I, Mielke R, Szelies B, Herholz K. Activation PET as an Instrument to Determine Therapeutic Efficacy in Alzheimer's Diseasea Annals of the New York Academy of Sciences. 695: 327-331. PMID 8239307 DOI: 10.1111/J.1749-6632.1993.Tb23078.X |
0.396 |
|
| 1992 |
Karbe H, Holthoff VA, Rudolf J, Herholz K, Heiss WD. Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia. Neurology. 42: 1540-4. PMID 1641150 DOI: 10.1212/Wnl.42.8.1540 |
0.413 |
|
| 1992 |
Herholz K, Heindel W, Luyten PR, denHollander JA, Pietrzyk U, Voges J, Kugel H, Friedmann G, Heiss WD. In vivo imaging of glucose consumption and lactate concentration in human gliomas. Annals of Neurology. 31: 319-27. PMID 1637139 DOI: 10.1002/Ana.410310315 |
0.388 |
|
| 1992 |
Herholz K, Rudolf J, Heiss WD. FDG transport and phosphorylation in human gliomas measured with dynamic PET. Journal of Neuro-Oncology. 12: 159-65. PMID 1560262 DOI: 10.1007/Bf00172667 |
0.366 |
|
| 1992 |
Karbe H, Grond M, Huber M, Herholz K, Kessler J, Heiss WD. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography. Journal of Neurology. 239: 98-102. PMID 1552311 DOI: 10.1007/Bf00862982 |
0.475 |
|
| 1992 |
Heiss W-, Huber M, Fink GR, Herholz K, Pietrzyk U, Wagner R, Wienhard K. Progressive derangement of periinfarct viable tissue in ischemic stroke. Journal of Cerebral Blood Flow and Metabolism. 12: 193-203. PMID 1548292 DOI: 10.1038/Jcbfm.1992.29 |
0.353 |
|
| 1992 |
Mielke R, Herholz K, Grond M, Kessler J, Heiss W-. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type Neurobiology of Aging. 13: 93-98. PMID 1542386 DOI: 10.1016/0197-4580(92)90015-P |
0.432 |
|
| 1992 |
Mielke R, Herholz K, Grond M, Kessler J, Heiss W. Severity of Vascular Dementia Is Related to Volume of Metabolically Impaired Tissue Jama Neurology. 49: 909-913. PMID 1520079 DOI: 10.1001/Archneur.1992.00530330031011 |
0.457 |
|
| 1992 |
Szelies B, Grond M, Herholz K, Kessler J, Wullen T, Heiss W-. Quantitative EEG mapping and PET in Alzheimer's disease. Journal of the Neurological Sciences. 110: 46-56. PMID 1506868 DOI: 10.1016/0022-510X(92)90008-9 |
0.453 |
|
| 1992 |
Huber M, Fink GR, Herholz K, Heiss W-. Metabolic derangement in viable periinfarct tissue in the course of acute ischaemic infarction: a multitracer positron emission tomography (PET) study. Neurological Research. 14: 184-186. PMID 1355884 DOI: 10.1080/01616412.1992.11740047 |
0.397 |
|
| 1992 |
Fink GR, Pietrzyk U, Herholz K, Huber M, Heiss W. Functional and morphological imaging of small striato-capsular infarction by CT, MRI and multitracer PET. Neurological Research. 14: 139-142. PMID 1355871 DOI: 10.1080/01616412.1992.11740034 |
0.428 |
|
| 1991 |
Kessler J, Herholz K, Grond M, Heiss W-. Impaired metabolic activation in Alzheimer's disease: A pet study during continuous visual recognition Neuropsychologia. 29: 229-243. PMID 2057055 DOI: 10.1016/0028-3932(91)90084-L |
0.466 |
|
| 1991 |
Karbe H, Wienhard K, Hamacher K, Huber M, Herholz K, Coenen HH, Stöcklin G, Lövenich A, Heiss WD. Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol Journal of Neural Transmission. 86: 163-173. PMID 1837996 DOI: 10.1007/Bf01250702 |
0.356 |
|
| 1991 |
Krieg J-, Holthoff V, Schreiber W, Pirke KM, Herholz K. Glucose metabolism in the caudate nuclei of patients with eating disorders, measured by PET. European Archives of Psychiatry and Clinical Neuroscience. 240: 331-333. PMID 1831664 DOI: 10.1007/Bf02279762 |
0.361 |
|
| 1991 |
Heiss W‐, Szelies B, Kessler J, Herholz K. Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PETa Annals of the New York Academy of Sciences. 640: 65-71. PMID 1776760 DOI: 10.1111/J.1749-6632.1991.Tb00192.X |
0.471 |
|
| 1991 |
Heiss W-, Kessler J, Szelies B, Grond M, Fink G, Herholz K. Positron emission tomography in the differential diagnosis of organic dementias Journal of Neural Transmission-Supplement. 33: 13-19. PMID 1753242 DOI: 10.1007/978-3-7091-9135-4_3 |
0.429 |
|
| 1990 |
Luyten PR, Marien AJ, Heindel W, van Gerwen PH, Herholz K, den Hollander JA, Friedmann G, Heiss WD. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology. 176: 791-9. PMID 2389038 DOI: 10.1148/Radiology.176.3.2389038 |
0.362 |
|
| 1990 |
Heiss W-, Herholz K, Podreka I, Neubauer I, Pietrzyk U. Comparison of [99mTc]HMPAO SPECT with [18F]fluoromethane PET in cerebrovascular disease. Journal of Cerebral Blood Flow and Metabolism. 10: 687-697. PMID 2384541 DOI: 10.1038/Jcbfm.1990.122 |
0.445 |
|
| 1990 |
Herholz K, Heindel W, Rackl A, Neubauer I, Steinbrich W, Pietrzyk U, Erasmi-Körber H, Heiss W. Regional cerebral blood flow in patients with leuko-araiosis and atherosclerotic carotid artery disease. Jama Neurology. 47: 392-396. PMID 2322132 DOI: 10.1001/Archneur.1990.00530040034016 |
0.338 |
|
| 1990 |
Karbe H, Szelies B, Herholz K, Heiss W-. Impairment of language is related to left parieto-temporal glucose metabolism in aphasic stroke patients. Journal of Neurology. 237: 19-23. PMID 2319264 DOI: 10.1007/Bf00319662 |
0.362 |
|
| 1990 |
Herholz K, Adams R, Kessler J, Szelies B, Grond M, Heiss W-. Criteria for the Diagnosis of Alzheimer's Disease with Positron Emission Tomography Dementia and Geriatric Cognitive Disorders. 1: 156-164. DOI: 10.1159/000107136 |
0.437 |
|
| 1989 |
Herholz K, Wienhard K, Pietrzyk U, Pawlik G, Heiss W-. Measurement of blood-brain hexose transport with dynamic PET: comparison of [18F]2-fluoro-2-deoxyglucose and [11C]O-methylglucose. Journal of Cerebral Blood Flow and Metabolism. 9: 104-110. PMID 2910891 DOI: 10.1038/Jcbfm.1989.14 |
0.386 |
|
| 1989 |
Karbe H, Herholz K, Szelies B, Pawlik G, Wienhard K, Heiss W-. Regional metabolic correlates of Token test results in cortical and subcortical left hemispheric infarction Neurology. 39: 1083-1083. PMID 2788250 DOI: 10.1212/Wnl.39.8.1083 |
0.335 |
|
| 1989 |
Huber M, Herholz K, Pawlik G, Szelies B, Jürgens R, Heiss W. Cerebral glucose metabolism in the course of subacute sclerosing panencephalitis Jama Neurology. 46: 97-100. PMID 2783367 DOI: 10.1001/Archneur.1989.00520370099029 |
0.376 |
|
| 1989 |
Baron JC, Frackowiak RS, Herholz K, Jones T, Lammertsma AA, Mazoyer B, Wienhard K. Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 9: 723-42. PMID 2684991 DOI: 10.1038/Jcbfm.1989.105 |
0.385 |
|
| 1989 |
Heiss W, Herholz K, Pawlik G, Hebold I, Klinkhammer P, Szelies B. Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects. The Keio Journal of Medicine. 38: 111-135. PMID 2674513 DOI: 10.2302/Kjm.38.111 |
0.463 |
|
| 1989 |
Heiss W-, Pawlik G, Herholz K, Szelies B, Wienhard K. Positron emission tomography as an imaging tool in psychiatric disorders Psychiatry Research-Neuroimaging. 29: 351-352. PMID 2532752 DOI: 10.1016/0165-1781(89)90086-3 |
0.415 |
|
| 1989 |
Heiss W-, Adams R, Kessler J, Szelies B, Herholz K. PET criteria for diagnosis of Alzheimer's disease and other dementias Journal of Neural Transmission - Parkinson's Disease and Dementia Section. 1: 32-32. DOI: 10.1007/bf02312212 |
0.345 |
|
| 1988 |
Herholz K. Non-stationary spatial filtering and accelerated curve fitting for parametric imaging with dynamic PET. European Journal of Nuclear Medicine and Molecular Imaging. 14: 477-484. PMID 3265103 DOI: 10.1007/Bf00252392 |
0.363 |
|
| 1988 |
Herholz K, Ziffling P, Staffen W, Pawlik G, Wagner R, Wienhard K, Heiss W. Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET. European Journal of Cancer and Clinical Oncology. 24: 1139-1150. PMID 3262062 DOI: 10.1016/0277-5379(88)90120-4 |
0.369 |
|
| 1988 |
Heiss W-, Hebold I, Klinkhammer P, Ziffling P, Szelies B, Pawlik G, Herholz K. Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography. Journal of Cerebral Blood Flow and Metabolism. 8: 613-617. PMID 3260597 DOI: 10.1038/Jcbfm.1988.104 |
0.463 |
|
| 1986 |
Heiss W-, Herholz K, Pawlik G, Wagner R, Wienhard K. Positron emission tomography in neuropsychology. Neuropsychologia. 24: 141-149. PMID 3486378 DOI: 10.1016/0028-3932(86)90048-5 |
0.437 |
|
| 1985 |
Gjedde A, Wienhard K, Heiss WD, Kloster G, Diemer NH, Herholz K, Pawlik G. Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 5: 163-78. PMID 3872872 DOI: 10.1038/Jcbfm.1985.23 |
0.335 |
|
| 1985 |
Heiss W-, Pawlik G, Herholz K, Wagner R, Wienhard K. Regional cerebral glucose metabolism in man during wakefulness,sleep,and dreaming Brain Research. 327: 362-366. PMID 3872693 DOI: 10.1016/0006-8993(85)91537-9 |
0.315 |
|
| 1985 |
Wienhard K, Pawlik G, Herholz K, Wagner R, Heiss W-. Estimation of local cerebral glucose utilization by positron emission tomography of [18F]2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures. Journal of Cerebral Blood Flow and Metabolism. 5: 115-125. PMID 3871780 DOI: 10.1038/Jcbfm.1985.15 |
0.351 |
|
| 1984 |
Heiss W-, Pawlik G, Herholz K, Wagner R, Göldner H, Wienhard K. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. Journal of Cerebral Blood Flow and Metabolism. 4: 212-223. PMID 6609929 DOI: 10.1038/Jcbfm.1984.30 |
0.397 |
|
| 1984 |
Pawlik G, Wienhard K, Herholz K, Wagner R, Heiss W-. Positron emission tomography study of regional glucose metabolism in cerebral ischemia--topographic and kinetic aspects. Progress in Brain Research. 62: 253-262. PMID 6335919 DOI: 10.1016/S0079-6123(08)62181-0 |
0.385 |
|
| 1984 |
Ilsen HW, Sato M, Pawlik G, Herholz K, Wienhard K, Heiss W-. (68Ga)-EDTA positron emission tomography in the diagnosis of brain tumors. Neuroradiology. 26: 393-398. PMID 6100508 DOI: 10.1007/Bf00327493 |
0.348 |
|
| Show low-probability matches. |